Global Trust Asset Management, LLC Abb Vie Inc. Transaction History

Global Trust Asset Management, LLC

$244 Million
Q2 2024

A detailed history of Global Trust Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 4,267 shares of ABBV stock, worth $828,651. This represents 0.3% of its overall portfolio holdings.

Number of Shares

4,267

Previous 4,291 0.56%

Holding current value

$828,651

Previous $781,000 6.4%

% of portfolio

0.3%

Previous 0.32%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$154.79 - $180.76 $3,714 - $4,338	-24 Reduced 0.56%	4,267 $731,000
Q4 2023 Jan 16, 2024	BUY	$137.6 - $154.97 $1,376 - $1,549	10 Added 0.23%	4,291 $664,000
Q3 2023 Oct 12, 2023	BUY	$133.59 - $154.65 $1,870 - $2,165	14 Added 0.33%	4,281 $638,000
Q2 2023 Jul 24, 2023	SELL	$132.51 - $164.9 $13,251 - $16,490	-100 Reduced 2.29%	4,267 $574,000
Q1 2023 Apr 14, 2023	BUY	$144.61 - $166.54 $28,922 - $33,308	200 Added 4.8%	4,367 $695,000
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $67,771 - $81,276	490 Added 13.33%	4,167 $673,000
Q3 2022 Oct 07, 2022	SELL	$134.21 - $153.93 $39,726 - $45,563	-296 Reduced 7.45%	3,677 $493,000
Q2 2022 Jul 12, 2022	SELL	$137.62 - $174.96 $277,992 - $353,419	-2,020 Reduced 33.71%	3,973 $609,000
Q1 2022 Apr 12, 2022	BUY	$131.98 - $163.75 $301,178 - $373,677	2,282 Added 61.49%	5,993 $972,000
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $253,319 - $320,522	2,358 Added 174.28%	3,711 $502,000
Q3 2021 Oct 07, 2021	BUY	$106.4 - $120.78 $319 - $362	3 Added 0.22%	1,353 $146,000
Q2 2021 Jul 13, 2021	BUY	$105.21 - $117.21 $315 - $351	3 Added 0.22%	1,350 $152,000
Q1 2021 Apr 14, 2021	SELL	$102.3 - $112.62 $4,705 - $5,180	-46 Reduced 3.3%	1,347 $146,000
Q4 2020 Jan 13, 2021	SELL	$80.49 - $108.67 $931,913 - $1.26 Million	-11,578 Reduced 89.26%	1,393 $149,000
Q3 2020 Nov 17, 2020	SELL	$85.91 - $100.83 $720,784 - $845,963	-8,390 Reduced 39.28%	12,971 $1.13 Million
Q2 2020 Jul 08, 2020	BUY	$73.37 - $98.18 $660,330 - $883,620	9,000 Added 72.81%	21,361 $2.1 Million
Q1 2020 Apr 06, 2020	SELL	$64.5 - $97.79 $1,935 - $2,933	-30 Reduced 0.24%	12,361 $930,000
Q3 2019 Oct 15, 2019	SELL	$62.98 - $75.72 $1.18 Million - $1.42 Million	-18,744 Reduced 60.2%	12,391 $938,000
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $1.18 Million - $1.51 Million	18,019 Added 137.38%	31,135 $956,000
Q1 2019 Apr 05, 2019	SELL	$77.14 - $90.79 $3,085 - $3,631	-40 Reduced 0.3%	13,116 $1.06 Million
Q4 2018 Jan 11, 2019	SELL	$77.85 - $96.01 $35,032 - $43,204	-450 Reduced 3.31%	13,156 $1.21 Million
Q3 2018 Oct 16, 2018	SELL	$88.91 - $98.84 $1,778 - $1,976	-20 Reduced 0.15%	13,606 $1.29 Million
Q2 2018 Jul 18, 2018	SELL	$89.78 - $106.23 $269,160 - $318,477	-2,998 Reduced 18.03%	13,626 $1.26 Million
Q1 2018 Apr 26, 2018	SELL	$92.01 - $123.21 $281,274 - $376,652	-3,057 Reduced 15.53%	16,624 $1.57 Million
Q4 2017 Feb 02, 2018	BUY	$89.56 - $98.21 $1.76 Million - $1.93 Million	19,681	19,681 $1.9 Million

Others Institutions Holding ABBV

# of Institutions

3,692

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $343B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Trust Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Trust Asset Management, LLC with notifications on news.

Account

Global Trust Asset Management, LLC Abb Vie Inc. Transaction History